I will accept if all answers are correct and detailed.

Business law case study, The Coca-Cola Company (Coca-Cola) was monitoring the cannabis industry and was interested in producing cannabis infused drinks using the non-psychoactive ingredient in marijuana that treated pain but didn't get the user high. Coca-Cola was in search of new alternatives to offset the drag on its soft drinks sale caused by consumer aversion toward carbonated, sugary drinks and it reportedly considered the booming marijuana industry to be a good source of revenue and profits for the company. According to the reports, this decision was taken as a punt for the distant future, when there would no longer be any soda-drinking customers to fall back upon. Is it worth the risk for Coca-Cola to enter into the cannabis market? This case study discusses the several reasons that could have triggered Coca-Cola's interest in entering the cannabis market by producing cannabis infused drinks. It also hints at the potential of the cannabis market, the growing interest of beverage companies in this space, and its expected growth in future. The case discusses the potential implications which this deal might have on the company, thereby enabling the students to discuss whether it would be a feasible option for Coca-Cola to adopt.

150 Should you treat a patient who has a brain cysticercosis lesion? The text seems to say 'Yes' but there is great uncertainty about it. Also, should one 'worm' the patient's gut when you find brain lesions; if so, with what?

151 Is there any rationale for giving either propranolol, valproate or buspirone to patients with cerebellar ataxia?

152 Is there a laboratory marker for cerebral dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL)? Is serum lactic acid elevated?

153 Primary brain tumours rarely metastasize outside the brain but malignancies outside the brain frequently metastasize to the brain. Why?

154 In a case of brain tumour, can papilloedema occur without a headache?

155 What are the pathological diagnostic features of glioblastoma multiforme?

156 Is acetazolamide effective in cases of normal pressure hydrocephalus? How effective is low-dose digoxin?

157 If dementia and incontinence are present, but gait apraxia is not, can normal pressure hydrocephalus be diagnosed?

158 Is a normal CT (plain and with contrast) in patients with headache, bilateral papilloedema and a clear conscious level sufficient to diagnose benign intracranial hypertension?

159 What is the value above which cerebrospinal fluid (CSF) pressure is said to be raised?

160 Could benign intracranial hypertension be diagnosed without headache as a complaint?